ASN
CYTH

Advisory Services Network’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Advisory Services Network’s Portfolio CYTH Stock Details CYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$1K – 3318
2021
Q2 		$1K Buy
+100
New +$837 ﹤0.01% 3532

Other funds holding CYTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisory Services Network's CYTH Position: Q3 2021 in Review

Advisory Services Network sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q3 2021, closing a stake of 100 shares — an estimated $1K sold.

Advisory Services Network first reported a position in CYTH in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 13 funds tracked by Wall St. Rank hold CYTH as of Q3 2021.

  • Advisory Services Network reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 100 Cyclo Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $1K.
  • Advisory Services Network first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Advisory Services Network's Cyclo Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.